Top Section/Ad
Top Section/Ad
Most recent
Two big infrastructure deals with private capital providers are fuelling hopes of a sustained M&A rebound in Germany
SMG’s drop below offer price sends mixed signals
SMG pares back gains after year’s largest IPO, Verisure to follow
Italy’s top independent investment bank must try to survive inside Monte dei Paschi
More articles/Ad
More articles/Ad
More articles
-
Cloopen Group Holding, a cloud-based communication provider, is planning to raise at least $100m from a US IPO of American depositary shares (ADS). -
Eurostar, the company which runs trains through the Channel Tunnel between London and Europe, is angling for a UK government-backed bailout loan. It is a ruse that can most generously be described as cheeky. If the company really needs cash to survive, there are many more appropriate ways of raising it in the capital markets.
-
Moonpig, the online greetings card company, has started its IPO process with a boost, announcing two big cornerstone orders at the beginning of investor education. Meanwhle, Dr Martens, the UK bootmaker, has published its intention to float on the London Stock Exchange without cornerstones, but sources say that either cornerstones or anchors are a strong possibility on that deal.
-
Immunocore, the UK biotech company, has filed for an IPO on the Nasdaq in New York following a $75m series ‘C’ funding round which concluded last week.
-
Primavera Capital Acquisition Corp, a special purpose acquisition company, is set to launch a $300m IPO on the New York Stock Exchange this week, extending a recent boom in Asia-focused Spacs.
-
Credit Suisse has boosted its investment banking operation in Japan by creating a new equity capital markets unit in the country.
